NCI has a Phase III clinical trial named Retroperitoneal Lymph Node Dissection in Treating Patients with Testicular Seminoma with Lymphadenopathy or Stage I-IIB Testicular Seminoma.

Sloan Kettering has a Phase I/II Study of Topical SOROO7 in Patients with Skin Metastasis from Cancer.